Zhejiang People's Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liang, Xiaodong
TQB2450-III-05, NCT04325763: A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

Recruiting
3
315
RoW
TQB2450, Anlotinib, TQB2450(blank), Anlotinib(blank)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Stage III Non-small-cell Lung Cancer
12/22
03/25
Qin, Zhiquan
NCT05622890: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Recruiting
3
35
RoW
Mirvetuximab Soravtansine, IMGN853, MIRV
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
04/23
12/23
G-HOPE-001, NCT06238843: A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma

Enrolling by invitation
3
450
RoW
irinotecan, IBI343, paclitaxel
Innovent Biologics (Suzhou) Co. Ltd.
Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
12/26
12/27
NOVA-II, NCT04088318: A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients

Active, not recruiting
2
170
US, RoW
OQL011, Vehicle Ointment
OnQuality Pharmaceuticals (USA) LLC
Hand-Foot Skin Reaction (HFSR)
02/24
06/24
NCT05555901: The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

Recruiting
2
116
RoW
Fruquintinib+ chemotherapy, Bevacizumab+ chemotherapy
Fudan University
Metastatic Colorectal Cancer
09/25
09/25
PM8002-A001, NCT05918445: PM8002 in the Treatment of Patients With Advanced Solid Tumors

Recruiting
1/2
380
RoW
PM8002
Biotheus Inc.
Malignant Neoplasm
11/25
11/25
NCT05914376: Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

Recruiting
1
24
RoW
Recombinant human IL-21-expressing oncolytic vaccinia virus injection, hV01
Hangzhou Converd Co., Ltd.
Advanced Solid Tumors
03/25
11/25

Download Options